Your browser doesn't support javascript.
loading
Risk factors, treatment, and outcome of central nervous system recurrence in adults with intermediate-grade and immunoblastic lymphoma.
van Besien, K; Ha, C S; Murphy, S; McLaughlin, P; Rodriguez, A; Amin, K; Forman, A; Romaguera, J; Hagemeister, F; Younes, A; Bachier, C; Sarris, A; Sobocinski, K S; Cox, J D; Cabanillas, F.
Affiliation
  • van Besien K; The Division of Medicine, Department of Hematology and Neuro-oncology, MD Anderson Cancer Center, Houston, TX, USA.
Blood ; 91(4): 1178-84, 1998 Feb 15.
Article in En | MEDLINE | ID: mdl-9454747
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, Non-Hodgkin / Antineoplastic Combined Chemotherapy Protocols / Central Nervous System Neoplasms / Precursor Cell Lymphoblastic Leukemia-Lymphoma Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Blood Year: 1998 Document type: Article Affiliation country: United States Country of publication: United States
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, Non-Hodgkin / Antineoplastic Combined Chemotherapy Protocols / Central Nervous System Neoplasms / Precursor Cell Lymphoblastic Leukemia-Lymphoma Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Blood Year: 1998 Document type: Article Affiliation country: United States Country of publication: United States